| 1 |
34051704 | A common genetic variant in fatty acid amide hydrolase is linked to alterations in fear extinction neural circuitry in a racially diverse, nonclinical sample of adults. | 2022 Mar |
1 |
| 2 |
34496065 | Genetic variation in endocannabinoid signaling is associated with differential network-level functional connectivity in youth. | 2022 Mar |
2 |
| 3 |
34756920 | Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells. | 2022 Feb |
3 |
| 4 |
34830856 | The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies. | 2021 Nov 15 |
2 |
| 5 |
32551466 | Non-opioid Analgesics and the Endocannabinoid System | 2020 Oct 23 |
1 |
| 6 |
32987725 | Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors. | 2020 Sep 24 |
1 |
| 7 |
30226747 | FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic Drug. | 2019 Jan 16 |
1 |
| 8 |
31407888 | New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation. | 2019 Dec 26 |
2 |
| 9 |
28150397 | Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. | 2018 Jan |
1 |
| 10 |
29695817 | Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. | 2018 Apr 26 |
3 |
| 11 |
29729263 | Enhanced endocannabinoid tone as a potential target of pharmacotherapy. | 2018 Jul 1 |
2 |
| 12 |
30114402 | Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. | 2018 Oct |
1 |
| 13 |
27989417 | 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability. | 2017 Feb 1 |
2 |
| 14 |
26505525 | Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold. | 2016 Jan 20 |
2 |
| 15 |
26808012 | Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer. | 2016 Feb |
1 |
| 16 |
27000802 | Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes. | 2016 Jun |
1 |
| 17 |
27309570 | Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents. | 2016 Jul 14 |
2 |
| 18 |
27582708 | Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management. | 2016 |
2 |
| 19 |
27806235 | Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase. | 2016 Nov 3 |
1 |
| 20 |
25519724 | A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells. | 2015 Feb |
1 |
| 21 |
25731744 | FAAH genetic variation enhances fronto-amygdala function in mouse and human. | 2015 Mar 3 |
1 |
| 22 |
26082009 | Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. | 2015 Nov |
2 |
| 23 |
26263913 | Inhibition of FAAH confers increased stem cell migration via PPARα. | 2015 Oct |
2 |
| 24 |
26408159 | The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review. | 2015 |
1 |
| 25 |
26413912 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014). | 2015 |
2 |
| 26 |
26561012 | Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture. | 2015 |
2 |
| 27 |
24705380 | Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. | 2014 |
1 |
| 28 |
25283614 | Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent. | 2014 Dec 15 |
1 |
| 29 |
22688188 | Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. | 2013 Jul |
1 |
| 30 |
23333123 | Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet. | 2013 May-Jun |
1 |
| 31 |
23344792 | The interaction of fatty acid amide hydrolase (FAAH) inhibitors with an anandamide carrier protein using (19)F-NMR. | 2013 Apr |
1 |
| 32 |
24223930 | Role of FAAH-like anandamide transporter in anandamide inactivation. | 2013 |
1 |
| 33 |
24445122 | Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients. | 2013 Dec |
1 |
| 34 |
21442624 | Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retinal pigment epithelial cells. | 2012 Feb |
1 |
| 35 |
21930339 | Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats. | 2012 Jan |
2 |
| 36 |
22133920 | Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP). | 2012 Feb 10 |
2 |
| 37 |
22146559 | Stable isotope liquid chromatography-tandem mass spectrometry assay for fatty acid amide hydrolase activity. | 2012 Feb 15 |
1 |
| 38 |
22609216 | Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance. | 2012 Jul-Aug |
2 |
| 39 |
22624680 | Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. | 2012 Nov |
1 |
| 40 |
22701012 | Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes. | 2012 Aug |
1 |
| 41 |
22776995 | A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity. | 2012 Dec |
4 |
| 42 |
21501143 | The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake. | 2011 Nov |
1 |
| 43 |
21505060 | Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. | 2011 Jul |
1 |
| 44 |
21631410 | Fatty acid amide hydrolase inhibitors--progress and potential. | 2011 Aug |
1 |
| 45 |
21645511 | Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase. | 2011 Sep 30 |
1 |
| 46 |
21666860 | Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. | 2011 Feb 10 |
1 |
| 47 |
21924613 | Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain. | 2011 Nov 1 |
2 |
| 48 |
22295023 | 385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population. | 2011 Jun |
2 |
| 49 |
20044928 | Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity. | 2010 Jan 1 |
1 |
| 50 |
20056290 | C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2. | 2010 Apr |
1 |